newsfilter
← Latest News
GlobeNewswire·

ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer

A total of 510 patients enrolledEvents required to trigger interim superiority analysis accruedInterim superiority analysis expected in Q1 2021; final analysis in Q4 2021 LYON, France and...